Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. Gross Profit 2010–2025
Supernus Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2013 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Supernus Pharmaceuticals Inc. gross profit for the quarter ending March 31, 2026 was 184.3 M, a 37.49% increase year-over-year.
- Supernus Pharmaceuticals Inc. gross profit for the twelve months ending March 31, 2026 was 640.1 M, a 12.28% increase year-over-year.
- Supernus Pharmaceuticals Inc. annual gross profit for 2025 was 644.4 M, a 10.36% increase from 2024.
- Supernus Pharmaceuticals Inc. annual gross profit for 2024 was 583.9 M, a 11.49% increase from 2023.
- Supernus Pharmaceuticals Inc. annual gross profit for 2023 was 523.7 M, a 9.70% decrease from 2022.
- Supernus Pharmaceuticals Inc. annual gross profit for 2022 was 580.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Supernus Pharmaceuticals Inc. Gross Profit — FAQ
Supernus Pharmaceuticals Inc. (SUPN) gross profit over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Supernus Pharmaceuticals Inc.'s gross profit?
Supernus Pharmaceuticals Inc. (SUPN) reported gross profit of $644M for fiscal 2025.
Where can I see SUPN's gross profit history?
The chart and table above show Supernus Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.